Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Bispecific antibody targets and services

Bispecific antibody targets and services

Bispecific antibody targets and services
Background

Bispecific antibodies (bsAbs) harness the specificities of two antibodies and combine them to simultaneously recognize different antigens or epitopes. This 'two-target' functionality has meant that interest in their use for therapeutic applications has increased considerably. With the development and maturity of bsAb technology platform, the combination selection of targets is becoming the key point of competition. Among the bsAb programs under development currently, the combination of CD3 and tumor surface targets are the most popular targets pairs. And the new targets of Immune cell will also provide more choice in targets combination in the future.

Hot targets
EGFR
VEGF
PD-1
GITR
TIM-3
LAG-3
BTLA
CD27
CD73
TGFbeta
DLL4
VEGFR2
ANGPT2
IL-6
HGF
cMET
HER3
LGR5
ICOS
CTLA-4
CD47
HER2
4-IBB
HIV-1 Env
CD4
CD32B
CD79B
CD20
CD95
TfR
BACE1
Tau
EGFRvIII
PD-L1
CD133
EpCAM
CLEC12
TROP2
CEA
FLT3
CD19
CD22
Claudin-18.2
GPC3
5T4
PSMA
CD28
FAP
MSLN
CD40
TA-MUC1
B7-H3
IL-13Ra2
GPA33
MUC16
Epha2
Cadherin-17
TRAIL R2
BCMA
NKp30
CD16
CD30
CD33
CD33
CD123
ROR1
CD38
IGF-I R
PSCA
DLL3
OX40
CD3

Click to find out the targets from ACROBiosystems

Free samples for bsAb hot targets are available!

Get it now

CD3 proteins
Features:
  1. > MALS verified heterodimer

  2. > High bioactivity and batch-to-batch consistency

  3. > Bioactivity verified by clinical bispecific antibody

  4. > Various tags and species

PD-1/PD-L1 Proteins
Features:
  1. > High purity and homogeneity

  2. > High bioactivity verified

  3. > Various tags and species


CD47 Proteins
Features:
  1. > High purity and homogeneity

  2. > High bioactivity verified

  3. > Suitable for immunization and inhibitor


Full length CD20 Proteins
Features:
  1. > Authentic conformation

  2. > Super bioactivity verified

  3. > Exclusive Nanodisc technology


Bioactivity analysis of bispecific antibody

The characterization and pharmacokinetic (PK)/PD assessment are vital. Quality attributes such as antigen specificity; affinity and on- and off-rates; avidity (for bispecific antibodies that target two molecules on the same cell); potency; process-related impurities such as aggregates, fragments, and homodimers; stability; and half-life may affect pharmacology and should be studied. On the other hand, as bispecific antibodies may present as a mixture of biologically active and inactive forms, it is important to identify the bispecific antibody form(s) that is most pharmacologically relevant to PK/PD assessment and to develop validated assays that measure the appropriate form(s) accordingly. Due to the synergetic effect BsAb brings, the dosage is relatively low. Therefore, it requires a more sensitive assay for analysis.

Case-study1: antigen-antibody affinity


Fig 1. Immobilized Human CD3E&CD3D Heterodimer Protein, His Tag&Tag Free (Cat. No. CDD-H52W1) at 2 μg/mL, add increasing concentrations of Bispecific T cell Engager (CD3 X BCMA)  and then add Biotinylated BCMA Fc,Avitag (Cat. No. BC7-H82F0) at 0.2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 4 ng/mL.

Case-study2: FcR-antibody affinity

                       
                       

Fig 2. Binding assay between bsAb and Fc receptor

Case-study3: Intact assay of bsAb


Fig 3. Immobilized Human OX40 Protein, His Tag (MALS verified) (Cat. No. OX0-H5224) at 2 μg/mL, add increasing concentrations of CTLA-4 x OX40 bispecific antibody in 50% Human serum and then add Biotinylated Human CTLA-4, Fc,Avitag (Cat. No. CT4-H82F3) at 0.2 μg/mL. Detection was performed using HRP-conjugated streptavidin with sensitivity of 4 ng/mL (Intact assay)

Methodology validation

Learn more about Bioactivity analysis of bispecific antibody

With a strong team of scientists, ACROBiosystems also provides high-quality integrated SPR&BLI analytical services. ACRO has served and collaborated with more than 100 customers from academia and industry. Our work supported multiple antibody drugs IND applications.
Click to learn more about SPR /BLI analytical service

ACRO Quality

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message